Ticarcillin Disodium/Clavulanate Potassium
- Generic Name
- Ticarcillin Disodium/Clavulanate Potassium
Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients
Phase 2
Completed
- Conditions
- DiabetesInfection
- Interventions
- Procedure: Percutaneous Isolated Limb Perfusion (PILP) delivery
- First Posted Date
- 2014-06-06
- Last Posted Date
- 2016-09-30
- Lead Sponsor
- Osprey Medical, Inc
- Target Recruit Count
- 15
- Registration Number
- NCT02158442
- Locations
- 🇦🇺
Royal Melbourne Hospital, Parkville, Victoria, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath